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Summary 
 
 A nursery study was conducted at the KSU 
Swine Teaching and Research Farm to evalu-
ate the effect of increasing dietary astaxanthin 
(0, 5, 10, and 25 ppm) on weanling pig per-
formance. Astaxanthin is a carotenoid found 
in various plants, algae, and seafood that ex-
hibits antioxidant and potential anti-
inflammatory properties that may be benefi-
cial during times of stress and reduced immu-
nity, such as weaning. A total of 210 pigs (ini-
tially 12.6 lb) were used in the 28-d experi-
ment.  Pigs were blocked by weight and ran-
domly allotted to one of five dietary treat-
ments. Pigs were fed simple corn-soybean 
meal-dried, whey-based diets during Phase 1 
(d 0 to 14); and corn-soybean meal diets in 
Phase 2 (d 14 to 28). Treatments consisted of 
a basal diet for each phase without added 
feed-grade antibiotic, or the basal diet with 5, 
10, or 25 ppm added astaxanthin without 
added feed-grade antibiotic; or the basal diet 
with a feed-grade antibiotic (Neo-Terramycin 
with 140 g of neomycin and 140 g of oxytet-
racycline per ton). For the d 0 to 14 (Phase 1) 
period, ADG and F/G were improved 
(P<0.05) by including a feed-grade antibiotic 
in the diet. Average daily gain and F/G of pigs 
fed astaxanthin was not different than control 
pigs. Pigs fed a feed-grade antibiotic during 
Phase 1 were heavier (P<0.05) on d 14 than 
were pigs fed 0, 5, or 10 ppm astaxanthin.  
They also tended to be heavier (P<0.10) than 
pigs fed 25 ppm astaxanthin.  For the overall 
Phase 2 period (d 14 to 28), pigs fed antibiotic 
had greater (P < 0.05) ADG than pigs fed 0, 5, 
and 25 ppm astaxanthin; the pigs fed 10 ppm 
astaxanthin had intermediate ADG.  Pigs fed 
antibiotic had greater (P<0.05) ADFI than 
pigs fed all other treatments.  Feed efficiency 
was improved (quadratic, P<0.07) as the level 
of astaxanthin increased to 10 ppm and then 
returned to control values at the 25 ppm level.  
Pigs fed antibiotic had poorer (P<0.05) F/G 
than pigs fed 0, 5, or 10 ppm astaxanthin, and 
pigs fed 25 ppm astaxanthin had poorer 
(P<0.05) F/G than pigs fed 10 ppm astaxan-
thin.  Overall (d 0 to 28), ADG, ADFI, and 
average weight on d 28 were improved 
(P<0.05) by including a feed-grade antibiotic 
in the diet.  Pigs fed 25 ppm astaxanthin or a 
feed-grade antibiotic had poorer (P<0.05 and 
P<0.10, respectively) F/G than pigs fed 10 
ppm astaxanthin.  In conclusion, the growth 
performance of pigs receiving 5, 10, or 25 
ppm of astaxanthin in the Phase 1 and Phase 2 
diets was not different than that of pigs fed the 
negative control diet.  However, ADG and 
ADFI were improved by including a feed-
grade antibiotic in the Phase 1 and Phase 2 
diets. 
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 1Appreciation is expressed to IGENE – Astaxanthin Partners, Ltd. for providing the Aquasta® astaxan-
thin, and for partial funding of the trial. 
2Food Animal Health and Management Center, College of Veterinary Medicine. 
 
Introduction 
 
 There is increasing public concern about 
the use of sub-therapeutic levels of feed-grade 
antibiotics in food animal production.  The 
judicious use of sub-therapeutic (or more 
commonly “growth promoter”) levels of anti-
biotics in food animal production has served 
to improve animal health, welfare, and per-
formance/production efficiency.  Most often, 
the use of these feed-grade antibiotics coin-
cides with periods of increased stress, such as 
weaning. 
 
 As a potential alternative to feed-grade 
antibiotics, there is increasing interest in iden-
tifying nutraceutical compounds. Nutricines 
are “natural” compounds found in various 
foodstuffs in trace amounts; they have proper-
ties that may improve health and immune 
function but lack an established requirement. 
An increasing understanding of potential 
nutraceutical compounds that may enhance 
immunity and health, and improve the ability 
to cope with periods of increased stress has 
stimulated interest in determining their suit-
ability as antibiotic replacements.  Few 
nutraceuticals, however, have been evaluated 
in studies measuring animal performance.  Of 
these, few have consistently and scientifically 
been demonstrated to improve animal per-
formance or successfully sustain a level of 
performance equal to that achieved with a 
feed-grade antibiotic. 
 
 Astaxanthin is used extensively in the 
aquaculture feed industry for its pigmentation 
characteristics.  Astaxanthin is a carotenoid 
that also has potent antioxidant properties and 
exists naturally in various plants, algae, and 
seafood.  Because of its antioxidant and poten-
tial anti-inflammatory characteristics, there is 
interest in evaluating astaxanthin as a 
nutraceutical in domestic animal species.  
These properties may be beneficial during 
times of stress and reduced immunity, such as 
weaning.  Thus, the objective of this experi- 
 
ment was to determine the influence of asta-
xanthin on growth performance of weanling 
pigs. 
 
Procedures 
 
Procedures used in this experiment were ap-
proved by the Kansas State University Animal 
Care and Use Committee.  The project was 
conducted at the KSU Swine Teaching and 
Research Farm.  Pens had a wire-mesh floor 
and provide approximately 3 ft2 per pig. Each 
pen was equipped with a four-hole, dry, self-
feeder and one nipple waterer providing ad 
libitum access to feed and water.  The facility 
was a mechanically ventilated room with a 
pull-plug manure storage pit. 
 
 A total of 210 pigs were weaned at an av-
erage of 12.6 lb and 21 d of age. Pigs were 
blocked by weight and randomly allotted to 
one of the five dietary treatments with six 
pens per treatment.  Each pen contained seven 
pigs.  Experimental diets were fed in meal 
form and maintained throughout two dietary 
phases (Table 1). The Phase 1 diet, fed from d 
0 to 14, was a corn-soybean meal-based diet 
containing 10% dried whey and 3.75% fish 
meal. The Phase 2 diet was fed from d 14 to 
28 and was a corn-soybean meal-based diet 
without specialty ingredients.  Astaxanthin (0, 
5, 10, and 25 ppm) or Neo-Terramycin (140 
g/ton of neomycin and 140 g/ton of oxytetra-
cycline) was added to the basal diets at the 
expense of corn starch to achieve the dietary 
treatments. Pigs and feeders were weighed on 
d 0, 7, 14, 21, and 28 post-weaning to deter-
mine the response criteria of ADG, ADFI, and 
F/G. 
 
Data were analyzed as a randomized com-
plete block design using the PROC MIXED 
procedure of SAS with pen as the experimen-
tal unit.  Linear and quadratic polynomial con-
trasts were used to determine the effects of 
increasing astaxanthin. 
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Results and Discussion for all other treatments.  Feed efficiency was 
improved (quadratic, P<0.07) as astaxanthin 
increased to 10 ppm; it then became poorer at 
the 25 ppm level.  Pigs fed antibiotic had 
poorer (P<0.05) F/G than pigs fed 0, 5, or 10 
ppm astaxanthin, and pigs fed 25 ppm astax-
anthin had poorer (P<0.05) F/G than pigs fed 
10 ppm astaxanthin. 
 
 The analyzed astaxanthin levels for the 
experimental diets containing added astaxan-
thin were 4.1, 9.6, and 23 ppm, similar to the 
targeted values of 5, 10, and 25 used in diet 
formulation. 
 
  For the d 0 to 14 (Phase 1) period, ADG 
and F/G were improved (P<0.05) by including 
a feed-grade antibiotic in the diet (Table 2).  
Pigs fed a feed-grade antibiotic were heavier 
(P<0.05) on d 14 than pigs fed 0, 5, or 10 ppm 
astaxanthin, and they tended to be heavier 
(P<0.10) than pigs fed 25 ppm astaxanthin. 
Pigs fed astaxanthin had similar performance 
to pigs fed the negative control diet. 
 
 Overall (d 0 to 28), ADG, ADFI, and av-
erage weight on d 28 were improved (P<0.05) 
by including a feed-grade antibiotic in the 
diet.  Pigs fed 25 ppm astaxanthin or a feed-
grade antibiotic had poorer (P<0.05 and 
P<0.10, respectively) F/G than those fed 10 
ppm astaxanthin. 
 
  In conclusion, the growth performance of 
pigs receiving 5, 10, or 25 ppm of astaxanthin 
in the Phase 1 and Phase 2 diets was not dif-
ferent than that of pigs receiving the negative 
control diet.  Including a feed-grade antibiotic 
in the diet improved ADG and ADFI during 
both phases and for the overall experiment. 
 For the Phase 2 period (d 14 to 28), ADG 
of pigs fed antibiotic was greater (P<0.05) 
than that of pigs fed 0, 5, and 25 ppm astaxan-
thin; pigs fed 10 ppm astaxanthin had inter-
mediate ADG.  Average daily feed intake was 
greater (P<0.05) for pigs fed antibiotic than  
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Table 1.  Composition of Experimental Dietsa
Ingredient Phase 1 Phase 2 
Corn 51.05 60.30 
Soybean meal (46.5% CP) 30.15 35.00 
Select menhaden fish meal 3.75 - 
Spray-dried edible whey 10.00 - 
Corn starch 0.77 0.77 
Soybean oil 1.00 - 
Monocalcium P (21% P) 1.20 1.50 
Limestone 0.75 1.10 
Salt 0.35 0.35 
L-lysine HCl 0.30 0.30 
DL-methionine 0.13 0.13 
L-threonine 0.15 0.15 
Vitamin premix 0.25 0.25 
Trace mineral premix 0.15 0.15 
Total 100.00 100.00 
  
Calculated analysis  
  Total lysine, % 1.55 1.45 
  True ileal digestible amino acids   
     Lysine, % 1.41 1.31 
     Isoleucine:lysine ratio, % 60 63 
     Leucine:lysine ratio, % 121 129 
     Methionine:lysine ratio, % 33 33 
     Met & Cys:lysine ratio, % 56 58 
     Threonine:lysine ratio, % 64 65 
     Tryptophan:lysine ratio, % 17 18 
     Valine:lysine ratio, % 66 69 
  Protein, % 22.4 21.9 
  ME, kcal/lb 1,520 1,498 
  TID lysine:ME ratio, g/Mcal 4.20 3.97 
  Ca, % 0.90 0.83 
  P, % 0.79 0.73 
  Available P, % 0.40 0.32 
aAstaxanthin (5, 10, or 25 ppm) or Neo-Terramycin (140g/ton Neomycin + 
140g/ton oxytetracycline) was added to the basal diets at the expense of corn 
starch to achieve the dietary treatments. 
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Table 2. Growth Performance of Nursery Pigs Fed Increasing Astaxanthin or a Feed-Grade Antibiotica
Added Astaxanthin, ppm P ≤ 
Astaxanthin 
Item 
Negative 
control 5 10 25 
Positive 
control 
SE 
Mean Linear Quadratic 
D 0 to 14        
  Initial weight, lb 12.58 12.56 12.59 12.58 12.59 0.61 - - 
  ADG, lb 0.29b 0.30b 0.30b 0.31b 0.37c 0.02 - - 
  ADFI, lb 0.37 0.38 0.37 0.39 0.43 0.03 - - 
  F/G 1.27 1.26 1.28 1.26 1.16 0.04 - - 
  D 14 weight, lb 16.69b 16.77b 16.72b 16.85bc 17.79c 0.75 - - 
D 14 to 28        
  ADG, lb 1.04b 1.02b 1.06bc 1.04b 1.13c 0.04 - - 
  ADFI, lb 1.32b 1.29b 1.32b 1.34b 1.49c 0.04 - - 
  F/G 1.27bc 1.27bc 1.24b 1.29cd 1.32d 0.01 - 0.064 
Overall, D 0 to 28        
  ADG, lb 0.67b 0.66b 0.68b 0.67b 0.75c 0.03 - - 
  ADFI, lb 0.84b 0.84b 0.85b 0.86b 0.96c 0.03 - - 
  F/G 1.27bc 1.27bc 1.25b 1.29c 1.28bc 0.01 - - 
  D 28 weight, lb 31.22b 31.05b 31.59b 31.37b 33.56c 1.17 - - 
aA total of 210 pigs were used in a 28-day, two-phase experiment to evaluate the growth performance of pigs 
fed increasing levels of Aquasta® astaxanthin (0, 5, 10, and 25 ppm).  A fifth treatment containing a growth-
promotant level of a feed-grade antibiotic (Neo-Terramycin) was also included as a positive control.  Six rep-
lications (pens) of 7 pigs per pen were utilized in a randomized complete block arrangement of treatments. 
Phase 1 diets were fed from d 0 to 14 and Phase 2 diets were fed from d 14 to 28 after weaning. 
b,c,dMeans in the same row with different superscripts differ P < 0.05. 
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